The updated guidance prioritizes older adults, high-risk individuals, and those who have never been vaccinated.
The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback